Pyrogen, when administered intravenously to normotensive and hypertensive men, produced initially vasoconstriction and subsequently marked renal vasodilatation, both resulting from direct effects on the renal vasculature. The absolute renal plasma flow, both during control observations and at the height of renal hyperemia, was greater in normotensives, but the percentage change was greater in hypertensive subjects. Extraction of p-aminohippurate diminished during renal hyperemia. Medullary renal plasma flow was higher in normotensive subjects both during control observations and at the height of renal hyperemia. Simultaneously with the development of renal hyperemia, sodium excretion increased without alterations in filtered load of sodium and was prompt in its development in normotensives and delayed in hypertensives. This is attributed to a transient, small, yet probably significant decrease in filtered load of sodium during vasoconstriction immediately following the administration of pyrogen.
Another variable thought of as affecting medullary tonicity is renal blood flow, medullary in particular. Since it was suggested that renal vascular disease or altered renal vascular reactivity may influence renal blood flow and thus be involved in the etiology of essential hypertension, we have embarked upon examining the question whether varying renal blood flow could produce differences between functional responses of normal subjects and those with essential hypertension.
Methods
We have examined the effect of renal hyperemia produced by intravenous administration of pyrogen* on renal hemodynamics, systemic *Supplied as Piromen (a mixture of nucleic acids and a polysaccharide complex that contains lipid and nitrogen) by Baxter Laboratories, Inc., Morton Grove, Illinois. 555 blood pressure, and excretion of sodium and total solute. Ten normotensive subjects without evidence of cardiovascular renal disease and 10 patients with essential hypertension, judged as being in early stages of the disease, and without clinical evidence of renal disease, were studied. All control subjects and those with essential hypertension were males.
Fluid was withheld for 8 hours preceding the test which was performed in the morning with the patient in the fasting state. Urine was collected through an indwelling catheter, and the bladder was emptied by means of air. After the administration of suitable priming doses of inulin and p-aminohippurate (PAH), sustaining infusion of these substances dissolved in normal saline was administered through a constant infusion pump at a rate of 1.8 ml/min. Three In order to evaluate whether "significant" changes in renal plasma flow attributable to pyrogen administration had occurred, the percentage random variation from the mean of three consecutive urine collection periods was examined for 28 normal subjects and 34 patients with essential hypertension while receiving sustaining infusions of p-aminohippurate in normal saline at rates of 1.8 ml/min.
The two groups were combined for this statistical evaluation. The variation amounted to 2.96% ± 1.53 (1 SD) of mean control RPF. Based on this comparison hyperemia was judged to be present when RPF increased more than 2 SD above the mean control values.
Calculations
The renal extraction of PAH was calculated from the formula E (A -V) /A where A is the peripheral venous concentration of PAH assumed to be identical to the renal arterial concentration and V is the renal venous concentration of PAH. 
Results

General Effects
Based on the effect of pyrogen on renal plasma flow two phases were distinguishable in the post-pyrogen periods: One (phase 1) started immediately after pyrogen administration. This phase was characterized by intense renal vasoconstriction and lasted 30 to 60 minutes. Phase 2 started 60 to 90 minutes after pyrogen administration and reached full development 100 to 210 minutes after pyrogen administration. This phase was characterized by progressive renal vasodilatation.
During phase 1, some subjects experienced headache and developed mild muscular aches. These complaints subsided shortly, but some felt chilly and required blankets to be comfortable. During phase 2, diaphoresis developed regularly and was followed by a return of a generalized feeling of well-being. Slight increase in temperature was observed in several instances, but fever above 100 F has never developed, possibly due to pretreatment with acetylsalicylic acid. found to increase in normal subjects in the flush phase after pyrogen administration. 4 While normotensive subjects seem capable of maintaining cardiac output during pyrogeninduced peripheral vasodilatation, hypertensive patients are unable to maintain peripheral resistance, this being associated with a fall in cardiac output5 and decrease in systemic arterial blood pressure.
Extraction (MRPF), appears to be much greater in the normotensive group. In this population, MRPF was higher during control periods in all four normotensives than in the four hypertensive patients. During the hyperemic phase the increment was greater in three of the four normotensive patients, but the mean increments for the two groups expressed as a percentage increase were comparable.
Antinatriuresis during phase 1 occurred in our studies in both normotensives and hypertensives but was most prominent in the latter group ( fig. 6 ). Lathem12 found, after typhoidparatyphoid-induced pyrogenic renal hyperemia in normotensive man, no systemic Figure 3 Efect of pyrogen on RPF in hypertensive subjects.
Circulation, Volume XXXVI, October 1967 Figure 4 Pyrogen-induced changes in EPAH, TRPF, and MRPF in normotensive and hypertensive subjects. Figure 6 Effect of pyrogen on RPF and EFNa in normotensive (Norm) and hypertensive (Hyp) subjects. increase in saluresis which finally was of comparable magnitude for the two groups. The absolute rate of this increase in sodium excretion was not of the extent observed by Baldwin and associates13 who found higher saluresis in hypertensives in response to low rate infusions of saline or hypotonic glucose. A defect in concentrating capacity seen at low solute loads is present in hypertensive patients. This impairment is being attributed to excessive sodium reabsorption in the proximal tubule, thus impairing the capacity to maintain medullary tonicity.' In our study this propensity for increased sodium reabsorption during phase 1 seemed again prorninent in the hypertensive group. The increase in solute excretion during the hyperemic phase was seen in both normotensives and hypertensives and has to be attributed to a decrease in sodium reabsorption. As Cf,,m increased, Circulation, Volume XXXVI, October 1967 TCH2O increased also, suggesting in addition an increase in antidiuretic hormone activity. The mean Cosm in the two groups were comparable both during control observations and at the height of hyperemia: for normotensives from 2.23 to 3.38 ml/min, an increase of 1.15 ml or 51.5%; for hypertensives from 2.45 to 3.67 ml/min, an increase of 1.22 ml or 49.8%. The mean Te120 during the same period in the two groups were also comparable although the percentage increase was greater in normotensives: for normotensives from 0.96 to 2.01 ml/min, an increase of 1.05 ml or 109%; for hypertensives from 1.43 to 1.94 ml/min, an increase of 0.51 or 35.6%. It is thought that medullary hyperemia minimizes medullary tonicity. In our study the pyrogeninduced increase in MRPF was greater in normotensives than in hypertensives, yet the magnitude of the tubular concentrating operation was comparable in the two populations. This suggests that medullary hyperemia, at least acutely, does not affect medullary tonicity.
